Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Clinical trial NCT02869217 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02869217
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients Synovial Sarcoma Melanoma Esophageal Cancer Ovarian Cancer Lung Cancer Bladder Cancer Liver Cancer

Start date: 2016-09-01
Primary completion: 2026-11-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.